#BEGIN_DRUGCARD DB03206

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
19130-96-2

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H13NO4

# Chemical_IUPAC_Name:
(2S,3S,4S,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Antiviral Agents
Beta-Glucosidase A Inhibitors
Enzyme Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-1.80

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-Deoxynojirimycin

# HET_ID:
NOJ

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m0/s1

# InChI_Key:
InChIKey=LXBIFEVIBLOUGU-FSIIMWSLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3206

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
163.1717

# Molecular_Weight_Mono:
163.084457909

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DOG

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.2

# Predicted_LogS:
0.5

# Predicted_Water_Solubility:
5.11e+02 g/l

# Primary_Accession_No:
DB03206

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
44387838

# PubChem_Substance_ID:
46507744

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01227
EXPT01236
EXPT02374

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H]1NC[C@@H](O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
1,5-Deoxy-1,5-imino-D-mannitol
1,5-Dideoxy-1,5-imino-D-glucitol
1-Deoxy-Nojirimycin
1-Deoxymannojirimycin
DNJ
DNM
NOJ

# Synthesis_Reference:
Not Available

# Toxicity:
ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.

# Update_Date:
2013-02-08 16:22:01 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum membrane
single-pass type II membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
MAN1B1

# Drug_Target_1_GenBank_ID_Gene:
AF148509

# Drug_Target_1_GenBank_ID_Protein:
6066222

# Drug_Target_1_GeneCard_ID:
MAN1B1

# Drug_Target_1_Gene_Name:
MAN1B1

# Drug_Target_1_Gene_Sequence:
>2100 bp
ATGGCTGCCTGCGAGGGCAGGAGAAGCGGAGCTCTCGGTTCCTCTCAGTCGGACTTCCTG
ACGCCGCCAGTGGGCGGGGCCCCTTGGGCCGTCGCCACCACTGTAGTCATGTACCCACCG
CCGCCGCCGCCGCCTCATCGGGACTTCATCTCGGTGACGCTGAGCTTTGGCGAGAGCTAT
GACAACAGCAAGAGTTGGCGGCGGCGCTCGTGCTGGAGGAAATGGAAGCAACTGTCGAGA
TTGCAGCGGAATATGATTCTCTTCCTCCTTGCCTTTCTGCTTTTCTGTGGACTCCTCTTC
TACATCAACTTGGCTGACCATTGGAAAGCTCTGGCTTTCAGGCTAGAGGAAGAGCAGAAG
ATGAGGCCAGAAATTGCTGGGTTAAAACCAGCAAATCCACCCGTCTTACCAGCTCCTCAG
AAGGCGGACACCGACCCTGAGAACTTACCTGAGATTTCGTCACAGAAGACACAAAGACAC
ATCCAGCGGGGACCACCTCACCTGCAGATTAGACCCCCAAGCCAAGACCTGAAGGATGGG
ACCCAGGAGGAGGCCACAAAAAGGCAAGAAGCCCCTGTGGATCCCCGCCCGGAAGGAGAT
CCGCAGAGGACAGTCATCAGCTGGAGGGGAGCGGTGATCGAGCCTGAGCAGGGCACCGAG
CTCCCTTCAAGAAGAGCAGAAGTGCCCACCAAGCCTCCCCTGCCACCGGCCAGGACACAG
GGCACACCAGTGCATCTGAACTATCGCCAGAAGGGCGTGATTGACGTCTTCCTGCATGCA
TGGAAAGGATACCGCAAGTTTGCATGGGGCCATGACGAGCTGAAGCCTGTGTCCAGGTCC
TTCAGTGAGTGGTTTGGCCTCGGTCTCACACTGATCGACGCGCTGGACACCATGTGGATC
TTGGGTCTGAGGAAAGAATTTGAGGAAGCCAGGAAGTGGGTGTCGAAGAAGTTACACTTT
GAAAAGGACGTGGACGTCAACCTGTTTGAGAGCACGATCCGCATCCTGGGGGGGCTCCTG
AGTGCCTACCACCTGTCTGGGGACAGCCTCTTCCTGAGGAAAGCTGAGGATTTTGGAAAT
CGGCTAATGCCTGCCTTCAGAACACCATCCAAGATTCCTTACTCGGATGTGAACATCGGT
ACTGGAGTTGCCCACCCGCCACGGTGGACCTCCGACAGCACTGTGGCCGAGGTGACCAGC
ATTCAGCTGGAGTTCCGGGAGCTCTCCCGTCTCACAGGGGATAAGAAGTTTCAGGAGGCA
GTGGAGAAGGTGACACAGCACATCCACGGCCTGTCTGGGAAGAAGGATGGGCTGGTGCCC
ATGTTCATCAATACCCACAGTGGCCTCTTCACCCACCTGGGCGTATTCACGCTGGGCGCC
AGGGCCGACAGCTACTATGAGTACCTGCTGAAGCAGTGGATCCAGGGCGGGAAGCAGGAG
ACACAGCTGCTGGAAGACTACGTGGAAGCCATCGAGGGTGTCAGAACGCACCTGCTGCGG
CACTCCGAGCCCAGTAAGCTCACCTTTGTGGGGGAGCTTGCCCACGGCCGCTTCAGTGCC
AAGATGGACCACCTGGTGTGCTTCCTGCCAGGGACGCTGGCTCTGGGCGTCTACCACGGC
CTGCCCGCCAGCCACATGGAGCTGGCCCAGGAGCTCATGGAGACTTGTTACCAGATGAAC
CGGCAGATGGAGACGGGGCTGAGTCCCGAGATCGTGCACTTCAACCTTTACCCCCAGCCG
GGCCGTCGGGACGTGGAGGTCAAGCCAGCAGACAGGCACAACCTGCTGCGGCCAGAGACC
GTGGAGAGCCTGTTCTACCTGTACCGCGTCACAGGGGACCGCAAATACCAGGACTGGGGC
TGGGAGATTCTGCAGAGCTTCAGCCGATTCACACGGGTCCCCTCGGGTGGCTATTCTTCC
ATCAACAATGTCCAGGATCCTCAGAAGCCCGAGCCTAGGGACAAGATGGAGAGCTTCTTC
CTGGGGGAGACGCTCAAGTATCTGTTCTTGCTCTTCTCCGATGACCCAAACCTGCTCAGC
CTGGACGCCTACGTGTTCAACACCGAAGCCCACCCTCTGCCTATCTGGACCCCTGCCTAG

# Drug_Target_1_General_Function:
Involved in mannosyl-oligosaccharide 1,2-alpha-mannosidase activity

# Drug_Target_1_General_References:
10409699	Gonzalez DS, Karaveg K, Vandersall-Nairn AS, Lal A, Moremen KW: Identification, expression, and characterization of a cDNA encoding human endoplasmic reticulum mannosidase I, the enzyme that catalyzes the first mannose trimming step in mammalian Asn-linked oligosaccharide biosynthesis. J Biol Chem. 1999 Jul 23;274(30):21375-86.
10521544	Tremblay LO, Herscovics A: Cloning and expression of a specific human alpha 1,2-mannosidase that trims Man9GlcNAc2 to Man8GlcNAc2 isomer B during N-glycan biosynthesis. Glycobiology. 1999 Oct;9(10):1073-8.
12975309	Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C, Currell B, Deuel B, Dowd P, Eaton D, Foster J, Grimaldi C, Gu Q, Hass PE, Heldens S, Huang A, Kim HS, Klimowski L, Jin Y, Johnson S, Lee J, Lewis L, Liao D, Mark M, Robbie E, Sanchez C, Schoenfeld J, Seshagiri S, Simmons L, Singh J, Smith V, Stinson J, Vagts A, Vandlen R, Watanabe C, Wieand D, Woods K, Xie MH, Yansura D, Yi S, Yu G, Yuan J, Zhang M, Zhang Z, Goddard A, Wood WI, Godowski P, Gray A: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003 Oct;13(10):2265-70. Epub 2003 Sep 15.

# Drug_Target_1_HGNC_ID:
HGNC:6823

# Drug_Target_1_HPRD_ID:
05068

# Drug_Target_1_ID:
2577

# Drug_Target_1_Locus:
9q34

# Drug_Target_1_Molecular_Weight:
79581

# Drug_Target_1_Name:
Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase

# Drug_Target_1_Number_of_Residues:
699

# Drug_Target_1_PDB_ID:
1X9D

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01532	Glyco_hydro_47

# Drug_Target_1_Protein_Sequence:
>Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase
MAACEGRRSGALGSSQSDFLTPPVGGAPWAVATTVVMYPPPPPPPHRDFISVTLSFGENY
DNSKSWRRRSCWRKWKQLSRLQRNMILFLLAFLLFCGLLFYINLADHWKALAFRLEEEQK
MRPEIAGLKPANPPVLPAPQKADTDPENLPEISSQKTQRHIQRGPPHLQIRPPSQDLKDG
TQEEATKRQEAPVDPRPEGDPQRTVISWRGAVIEPEQGTELPSRRAEVPTKPPLPPARTQ
GTPVHLNYRQKGVIDVFLHAWKGYRKFAWGHDELKPVSRSFSEWFGLGLTLIDALDTMWI
LGLRKEFEEARKWVSKKLHFEKDVDVNLFESTIRILGGLLSAYHLSGDSLFLRKAEDFGN
RLMPAFRTPSKIPYSDVNIGTGVAHPPRWTSDSTVAEVTSIQLEFRELSRLTGDKKFQEA
VEKVTQHIHGLSGKKDGLVPMFINTHSGLFTHLGVFTLGARADSYYEYLLKQWIQGGKQE
TQLLEDYVEAIEGVRTHLLRHSEPSKLTFVGELAHGRFSAKMDHLVCFLPGTLALGVYHG
LPASHMELAQELMETCYQMNRQMETGLSPEIVHFNLYPQPGRRDVEVKPADRHNLLRPET
VESLFYLYRVTGDRKYQDWGWEILQSFSRFTRVPSGGYSSINNVQDPQKPEPRDKMESFF
LGETLKYLFLLFSDDPNLLSLDAYVFNTEAHPLPIWTPA

# Drug_Target_1_Reaction:
Hydrolysis of the terminal 1,2-linked alpha-D-mannose residues in the oligo-mannose oligosaccharide Man9(GlcNAc)2 ALL_REAC (other) R05982(G) R06722(G)

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Involved in the maturation of Asn-linked oligosaccharides. Trim a single alpha-1,2-linked mannose residue from Man(9)GlcNAc(2) to produce Man(8)GlcNAc(2). The only product is the Man(8)GlcNAc(2) isomer B, the form lacking the middle-arm terminal alpha 1,2-mannose. It may be involved in glycoprotein quality control since it is important to target misfolded glycoproteins for degradation

# Drug_Target_1_SwissProt_ID:
Q9UKM7

# Drug_Target_1_SwissProt_Name:
MA1B1_HUMAN

# Drug_Target_1_Synonyms:
EC 3.2.1.113
ER alpha-1,2-mannosidase
Man9GlcNAc2-specific-processing alpha-mannosidase
Mannosidase alpha class 1B member 1

# Drug_Target_1_Theoretical_pI:
7.80

# Drug_Target_1_Transmembrane_Regions:
85-105

# Drug_Target_2_Cellular_Location:
Secreted protein

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
D45839

# Drug_Target_2_GenBank_ID_Protein:
987684

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
MSDC

# Drug_Target_2_Gene_Sequence:
>1536 bp
ATGCGTCTTCCAGTGTCATTCCCTCTGACAGTTCTGAGCTTGTTGGGCTCGACAATTGCT
CATCCCTATGGCGAGACCGAGGCTGTTTTGCGAAGTGAGCCTAAGAGTAACCAAGCCAAA
GCCGACGCTGTCAAAGAGGCCTTCCAGCACGCGTGGAATGGATACATGAAATATGCCTTC
CCTCATGACGAGTTGACTCCTGTCAGCAATGGTCATGCCGACTCTAGAAATGGATGGGGG
GCCTCAGCAGTTGACGCGCTTTCCACGGCCGTGATTATGGGCAAAGCGGATGTTGTGAAT
GCCATTCTCGAGCATGTCGCCGACATTGACTTCTCGAAGACCTCGGATACCGTCAGTCTT
TTCGAAACAACCATTCGTTACTTGGCGGGTATGCTATCGGGTTACGATCTGCTTCAGGGA
CCTGCCAAGAATTTGGTCGATAACCAAGACCTCATTGACGGATTACTGGACCAGTCAAGA
AACCTGGCCGATGTTCTGAAATTTGCTTTCGATACCCCTTCGGGTGTCCCCTATAATAAC
ATCAACATCACCTCGCACGGAAATGACGGCGCAACCACTAATGGCCTCGCTGTGACTGGC
ACACTGGTTCTGGAATGGACTCGTCTTTCTGATCTGACAGGTGATGAAGAGTATGCCAAA
TTAAGCCAGAAGGCCGAGTCTTATCTGCTCAAGCCGCAGCCATCGAGCAGCGAGCCTTTC
CCTGGTCTCGTAGGCAGCTCGATTAATATCAACGATGGTCAATTTGCCGACTCCAGAGTC
TCTTGGAATGGAGGTGACGATTCATTCTATGAGTACCTGATCAAGATGTACGTGTACGAC
CCTAAGCGGTTTGAGACATACAAGGATCGCTGGGTCCTGGCAGCCGAGTCGACTATCAAG
CATCTCAAGTCGCACCCGAAGTCCCGCCCGGACTTGACGTTCCTGTCTTCCTACAGTAAC
AGGAATTATGATCTCAGCTCGCAGCACCTGACTTGCTTCGATGGCGGTAGTTTTCTTCTG
GGCGGTACCGTTCTGGACCGCCAGGACTTCATTGATTTTGGTCTGGAGCTTGTTGACGGC
TGTGAGGCTACCTACAATTCTACTCTGACCAAGATCGGTCCAGACTCGTGGGGCTGGGAC
CCAAAGAAGGTCCCCAGTGACCAGAAAGAATTCTATGAAAAAGCTGGCTTCTATATCAGT
AGTGGTTCGTACGTCCTCCGCCCCGAGGTGATTGAAAGTTTTTACTACGCGCACCGCGTT
ACTGGAAAGGAAATTTACCGTGACTGGGTTTGGAATGCGTTCGTTGCAATTAACTCGACC
TGCCGTACCGACTCTGGTTTCGCTGCTGTATCCGACGTCAACAAGGCGAACGGTGGCTCC
AAGTACGACAACCAAGAGAGTTTCCTCTTCGCCGAGGTCATGAAGTACTCATATCTCGCT
CATTCCGAGGATGCTGCATGGCAAGTCCAGAAGGGTGGCAAGAATACCTTCGTGTACAAC
ACTGAGGCTCACCCGATTAGCGTCGCACGCAACTAA

# Drug_Target_2_General_Function:
Involved in mannosyl-oligosaccharide 1,2-alpha-mannosidase activity

# Drug_Target_2_General_References:
7640307	Yoshida T, Ichishima E: Molecular cloning and nucleotide sequence of the genomic DNA for 1,2-alpha-D-mannosidase gene, msdC from Penicillium citrinum. Biochim Biophys Acta. 1995 Aug 22;1263(2):159-62.
8452520	Yoshida T, Inoue T, Ichishima E: 1,2-alpha-D-mannosidase from Penicillium citrinum: molecular and enzymic properties of two isoenzymes. Biochem J. 1993 Mar 1;290 ( Pt 2):349-54.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3258

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
56570

# Drug_Target_2_Name:
Mannosyl-oligosaccharide alpha-1,2-mannosidase

# Drug_Target_2_Number_of_Residues:
511

# Drug_Target_2_PDB_ID:
1KKT

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01532	Glyco_hydro_47

# Drug_Target_2_Protein_Sequence:
>Mannosyl-oligosaccharide alpha-1,2-mannosidase precursor
MRLPVSFPLTVLSLLGSTIAHPYGETEAVLRSEPKSNQAKADAVKEAFQHAWNGYMKYAF
PHDELTPVSNGHADSRNGWGASAVDALSTAVIMGKADVVNAILEHVADIDFSKTSDTVSL
FETTIRYLAGMLSGYDLLQGPAKNLVDNQDLIDGLLDQSRNLADVLKFAFDTPSGVPYNN
INITSHGNDGATTNGLAVTGTLVLEWTRLSDLTGDEEYAKLSQKAESYLLKPQPSSSEPF
PGLVGSSININDGQFADSRVSWNGGDDSFYEYLIKMYVYDPKRFETYKDRWVLAAESTIK
HLKSHPKSRPDLTFLSSYSNRNYDLSSQHLTCFDGGSFLLGGTVLDRQDFIDFGLELVDG
CEATYNSTLTKIGPDSWGWDPKKVPSDQKEFYEKAGFYISSGSYVLRPEVIESFYYAHRV
TGKEIYRDWVWNAFVAINSTCRTDSGFAAVSDVNKANGGSKYDNQESFLFAEVMKYSYLA
HSEDAAWQVQKGGKNTFVYNTEAHPISVARN

# Drug_Target_2_Reaction:
Hydrolysis of the terminal 1,2-linked alpha-D-mannose residues in the oligo-mannose oligosaccharide Man9(GlcNAc)2 ALL_REAC (other) R05982(G) R06722(G)

# Drug_Target_2_Signals:
1-35

# Drug_Target_2_Specific_Function:
Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2)

# Drug_Target_2_SwissProt_ID:
P31723

# Drug_Target_2_SwissProt_Name:
MAN12_PENCI

# Drug_Target_2_Synonyms:
EC 3.2.1.113
Man(9)-alpha-mannosidase
Mannosyl-oligosaccharide alpha-1,2-mannosidase precursor

# Drug_Target_2_Theoretical_pI:
4.83

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
2304904	Collyer CA, Blow DM: Observations of reaction intermediates and the mechanism of aldose-ketose interconversion by D-xylose isomerase. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1362-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X59466

# Drug_Target_3_GenBank_ID_Protein:
39059

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
xylA

# Drug_Target_3_Gene_Sequence:
>1188 bp
ATGAGCGTTCAGCCGACCCCTGCAGACCACTTCACCTTTGGCCTCTGGACCGTAGGATGG
ACCGGCGCCGACCCATTCGGTGTCGCCACCCGCAAGAACCTGGACCCGGTAGAAGCCGTC
CACAAGCTGGCCGAGCTCGGCGCCTACGGCATCACCTTCCACGACAATGACCTGATTCCT
TTTGACGCCACCGAGGCAGAGCGCGAAAAGATCCTTGGTGACTTCAACCAGGCGCTGAAG
GACACCGGCCTGAAGGTCCCAATGGTGACCACCAACCTGTTCAGCCACCCGGTCTTCAAG
GACGGCGGCTTCACCTCTAACGACCGCTCGATCCGTCGTTTTGCACTGGCTAAGGTCCTG
CACAACATCGACTTGGCAGCCGAGATGGGCGCCGAAACCTTCGTCATGTGGGGCGGGCGC
GAAGGCAGCGAATACGACGGTTCCAAGGACCTGGCCGCAGCACTTGATCGCATGCGCGAA
GGCGTGGACACGGCAGCTGGCTACATCAAGGACAAGGGTTACAACCTGCGCATCGCGCTG
GAGCCAAAGCCAAATGAACCACGCGGCGACATCTTCCTGCCTACCGTCGGCCACGGCCTG
GCCTTCATCGAGCAGCTGGAGCACGGCGACATCGTCGGCCTGAACCCAGAAACCGGCCAC
GAGCAGATGGCCGGCCTGAACTTCACCCACGGCATCGCTCAGGCACTGTGGGCCGAGAAG
CTGTTCCACATTGACCTCAACGGCCAGCGCGGCATCAAGTACGACCAGGACCTGGTCTTC
GGCCACGGCGATCTGACCAGCGCGTTCTTCACCGTAGACCTGCTGGAAAACGGCTTCCCT
AACGGCGGACCAAAGTACACCGGCCCACGCCACTTCGACTACAAGCCATCGCGCACCGAC
GGCTACGACGGCGTGTGGGACTCGGCCAAGGCCAACATGTCCATGTACCTGCTGCTCAAG
GAACGTGCCCTGGCCTTCCGTGCGGATCCAGAGGTACAGGAAGCCATGAAGACCTCGGGC
GTCTTCGAACTGGGCGAAACCACCCTGAACGCCGGGGAAAGCGCAGCGGATCTGATGAAT
GATTCCGCGAGCTTCGCAGGCTTTGACGCCGAGGCCGCCGCAGAGCGCAACTTCGCGTTC
ATCCGCCTGAACCAGCTGGCCATCGAGCACCTGCTCGGCTCCCGCTAA

# Drug_Target_3_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_3_General_References:
1854338	Smith CA, Rangarajan M, Hartley BS: D-Xylose (D-glucose) isomerase from Arthrobacter strain N.R.R.L. B3728. Purification and properties. Biochem J. 1991 Jul 1;277 ( Pt 1):255-61.
1854339	Loviny-Anderton T, Shaw PC, Shin MK, Hartley BS: D-Xylose (D-glucose) isomerase from Arthrobacter strain N.R.R.L. B3728. Gene cloning, sequence and expression. Biochem J. 1991 Jul 1;277 ( Pt 1):263-71.
2319597	Collyer CA, Henrick K, Blow DM: Mechanism for aldose-ketose interconversion by D-xylose isomerase involving ring opening followed by a 1,2-hydride shift. J Mol Biol. 1990 Mar 5;212(1):211-35.
2769749	Henrick K, Collyer CA, Blow DM: Structures of D-xylose isomerase from Arthrobacter strain B3728 containing the inhibitors xylitol and D-sorbitol at 2.5 A and 2.3 A resolution, respectively. J Mol Biol. 1989 Jul 5;208(1):129-57.
3508294	Henrick K, Blow DM, Carrell HL, Glusker JP: Comparison of backbone structures of glucose isomerase from Streptomyces and Arthrobacter. Protein Eng. 1987 Dec;1(6):467-9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2253

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
43292

# Drug_Target_3_Name:
Xylose isomerase

# Drug_Target_3_Number_of_Residues:
395

# Drug_Target_3_PDB_ID:
1XLL

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01261	AP_endonuc_2

# Drug_Target_3_Protein_Sequence:
>Xylose isomerase
MSVQPTPADHFTFGLWTVGWTGADPFGVATRKNLDPVEAVHKLAELGAYGITFHDNDLIP
FDATEAEREKILGDFNQALKDTGLKVPMVTTNLFSHPVFKDGGFTSNDRSIRRFALAKVL
HNIDLAAEMGAETFVMWGGREGSEYDGSKDLAAALDRMREGVDTAAGYIKDKGYNLRIAL
EPKPNEPRGDIFLPTVGHGLAFIEQLEHGDIVGLNPETGHEQMAGLNFTHGIAQALWAEK
LFHIDLNGQRGIKYDQDLVFGHGDLTSAFFTVDLLENGFPNGGPKYTGPRHFDYKPSRTD
GYDGVWDSAKANMSMYLLLKERALAFRADPEVQEAMKTSGVFELGETTLNAGESAADLMN
DSASFAGFDAEAAAERNFAFIRLNQLAIEHLLGSR

# Drug_Target_3_Reaction:
D-xylose = D-xylulose

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
D-xylose = D-xylulose

# Drug_Target_3_SwissProt_ID:
P12070

# Drug_Target_3_SwissProt_Name:
XYLA_ARTS7

# Drug_Target_3_Synonyms:
EC 5.3.1.5

# Drug_Target_3_Theoretical_pI:
4.73

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X74163

# Drug_Target_4_GenBank_ID_Protein:
395291

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
bglA

# Drug_Target_4_Gene_Sequence:
>1341 bp
ATGAACGTGAAAAAGTTCCCTGAAGGATTCCTCTGGGGTGTTGCAACAGCTTCCTACCAG
ATCGAGGGTTCTCCCCTCGCAGACGGAGCTGGTATGTCTATCTGGCACACCTTCTCCCAT
ACTCCTGGAAATGTAAAGAACGGTGACACGGGAGATGTGGCCTGCGACCACTACAACAGA
TGGAAAGAGGACATTGAAATCATAGAGAAACTCGGAGTAAAGGCTTACAGATTTTCAATC
AGCTGGCCAAGAATACTTCCGGAAGGAACAGGAAGGGTGAATCAGAAAGGACTGGATTTT
TACAACAGGATCATAGACACCCTGCTGGAAAAAGGTATCACACCCTTTGTGACCATCTAT
CACTGGGATCTTCCCTTCGCTCTTCAGCTGAAAGGAGGATGGGCGAACAGAGAAATAGCG
GATTGGTTCGCAGAATACTCAAGGGTTCTCTTTGAAAATTTCGGTGATCGTGTGAAGAAC
TGGATCACCTTGAACGAACCGTGGGTTGTTGCCATAGTGGGGCATCTGTACGGAGTCCAC
GCTCCTGGAATGAGAGATATTTACGTGGCTTTCCGAGCTGTTCACAATCTCTTGAGGGCA
CACGCCAGAGCGGTGAAAGTGTTCAGGGAAACCGTGAAAGATGGAAAGATCGGAATAGTT
TTCAACAATGGATATTTCGAACCTGCGAGTGAAAAAGAAGAAGACATCAGAGCGGTGAGA
TTCATGCATCAGTTCAACAACTATCCTCTCTTTCTCAATCCGATCTACAGAGGAGATTAC
CCGGAGCTCGTTCTGGAATTTGCCAGAGAGTATCTACCGGAGAATTACAAAGATGACATG
TCCGAGATACAGGAAAAGATCGACTTTGTTGGATTGAACTATTACTCCGGTCATTTGGTG
AAGTTCGATCCAGATGCACCAGCTAAGGTCTCTTTCGTTGAAAGGGATCTTCCAAAAACA
GCCATGGGATGGGAGATCGTTCCAGAAGGAATCTACTGGATCCTGAAGAAGGTGAAAGAA
GAATACAACCCACCAGAGGTTTACATCACAGAGAATGGGGCTGCTTTTGACGACGTAGTT
AGTGAAGATGGAAGAGTTCACGATCAAAACAGAATCGATTATTTGAAGGCCCACATTGGT
CAGGCATGGAAGGCCATACAGGAGGGAGTGCCGCTTAAAGGTTACTTCGTCTGGTCGCTC
CTCGACAATTTCGAATGGGCAGAGGGATATTCCAAGAGATTTGGTATTGTGTATGTAGAC
TACAGCACTCAAAAACGCATCGTAAAAGACAGTGGGTACTGGTACTCGAATGTGGTTAAA
AACAACGGTCTGGAAGACTGA

# Drug_Target_4_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_4_General_References:
8277941	Liebl W, Gabelsberger J, Schleifer KH: Comparative amino acid sequence analysis of Thermotoga maritima beta-glucosidase (BglA) deduced from the nucleotide sequence of the gene indicates distant relationship between beta-glucosidases of the BGA family and other families of beta-1,4-glycosyl hydrolases. Mol Gen Genet. 1994 Jan;242(1):111-5.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3298

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
51549

# Drug_Target_4_Name:
Beta-glucosidase A

# Drug_Target_4_Number_of_Residues:
446

# Drug_Target_4_PDB_ID:
1OD0

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00232	Glyco_hydro_1

# Drug_Target_4_Protein_Sequence:
>Beta-glucosidase A
MNVKKFPEGFLWGVATASYQIEGSPLADGAGMSIWHTFSHTPGNVKNGDTGDVACDHYNR
WKEDIEIIEKLGVKAYRFSISWPRILPEGTGRVNQKGLDFYNRIIDTLLEKGITPFVTIY
HWDLPFALQLKGGWANREIADWFAEYSRVLFENFGDRVKNWITLNEPWVVAIVGHLYGVH
APGMRDIYVAFRAVHNLLRAHARAVKVFRETVKDGKIGIVFNNGYFEPASEKEEDIRAVR
FMHQFNNYPLFLNPIYRGDYPELVLEFAREYLPENYKDDMSEIQEKIDFVGLNYYSGHLV
KFDPDAPAKVSFVERDLPKTAMGWEIVPEGIYWILKKVKEEYNPPEVYITENGAAFDDVV
SEDGRVHDQNRIDYLKAHIGQAWKAIQEGVPLKGYFVWSLLDNFEWAEGYSKRFGIVYVD
YSTQKRIVKDSGYWYSNVVKNNGLED

# Drug_Target_4_Reaction:
Hydrolysis of terminal, non-reducing beta-D-glucose residues with release of beta-D-glucose ALL_REAC (other) R00026 R02887 R03527 R04949 R04998 R06077(G) R06092(G)

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Hydrolysis of terminal, non-reducing beta-D- glucose residues with release of beta-D-glucose

# Drug_Target_4_SwissProt_ID:
Q08638

# Drug_Target_4_SwissProt_Name:
BGLA_THEMA

# Drug_Target_4_Synonyms:
Beta-D- glucoside glucohydrolase
Cellobiase
EC 3.2.1.21
Gentiobiase

# Drug_Target_4_Theoretical_pI:
5.64

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
M17366

# Drug_Target_5_GenBank_ID_Protein:
142676

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
cgt

# Drug_Target_5_Gene_Sequence:
>2142 bp
ATGAAAAGATTTATGAAACTAACAGCCGTATGGACACTCTGGTTATCCCTCACGCTGGGC
CTCTTGAGCCCGGTCCACGCAGCCCCGGATACCTCGGTATCCAACAAGCAGAATTTCAGC
ACGGATGTCATATATCAGATCTTCACCGACCGGTTCTCGGACGGCAATCCGGCCAACAAT
CCGACCGGCGCGGCATTTGACGGATCATGTACGAATCTTCGCTTATACTGCGGCGGCGAC
TGGCAAGGCATCATCAACAAAATCAACGACGGTTATTTGACCGGCATGGGCATTACGGCC
ATCTGGATTTCACAGCCTGTCGAGAATATCTACAGCGTGATCAACTACTCCGGCGTCAAT
AATACGGCTTATCACGGCTACTGGGCCCGGGACTTCAAGAAGACCAATCCGGCCTACGGG
ACGATGCAGGACTTCAAAAACCTGATCGACACCGCGCATGCGCATAACATAAAAGTCATC
ATCGACTTTGCACCGAACCATACATCTCCGGCTTCTTCGGATGATCCTTCTTTTGCAGAG
AACGGCCGCTTGTACGATAACGGCAACCTGCTCGGCGGATACACCAACGATACCCAAAAT
CTGTTCCACCATTATGGCGGCACGGATTTCTCCACCATTGAGAACGGCATTTATAAAAAC
CTGTACGATCTGGCTGACCTGAATCATAACAACAGCAGCGTCGATGTGTATCTGAAGGAT
GCCATCAAAATGTGGCTCGACCTCGGGGTGGACGGCATTCGCGTGGACGCGGTCAAGCAT
ATGCCATTCGGCTGGCAGAAGAGCTTTATGGCCACCATTAACAACTACAAGCCGGTCTTC
ACCTTCGGCGAATGGTTCCTAGGCGTCAATGAGATCAGTCCGGAATACCATCAATTCGCT
AACGAGTCCGGGATGAGCCTGCTCGATTTCCGCTTTGCCCAGAAGGCTCGGCAAGTGTTC
AGGGACAACACCGACAATATGTACGGCCTGAAGGCGATGCTGGAGGGCTCTGAAGTAGAC
TATGCCCAGGTGAATGACCAGGTGACCTTCATCGACAATCATGACATGGAGCGTTTCCAC
ACCAGCAATGGCGACAGACGGAAGCTGGAGCAGGCGCTGGCCTTTACCCTGACTTCACGC
GGTGTGCCTGCCATCTATTACGGCAGCGAGCAGTATATGTCTGGCGGGAATGATCCGGAC
AACCGTGCACGACTTCCTTCCTTCTCCACGACGACGACCGCATATCAAGTCATCCAAAAG
CTCGCTCCGCTCCGCAAATCCAACCCGGCCATCGCTTACGGTTCCACACATGAGCGCTGG
ATCAACAACGATGTGATCATCTATGAACGCAAATTCGGCAATAACGTGGCCGTTGTTGCC
ATTAACCGCAATATGAACACACCGGCTTCAATTACCGGCCTTGTCACTTCCCTCCGCAGG
GCCAGCTATAACGATGTGCTCGGCGGAATTCTGAACGGCAATACGCTAACCGTGGGTGCT
GGCGGTGCAGCTTCCAACTTTACCCTGGCTCCTGGCGGCACTGCTGTATGGCAGTACACA
ACCGATGCCACAACTCCGATCATCGGCAATGTCGGTCCGATGATGGCAAAGCCAGGGGTC
ACGATTACGATTGACGGCCGCGGCTTCGGCTCCGGCAAGGGAACGGTTTACTTCGGTACA
ACGGCAGTCACTGGCGCGGACATCGTAGCTTGGGAAGATACACAGATTCAGGTGAAAATC
CCTGCGGTCCCTGGCGGCATCTATGATATCAGAGTTGCCAACGCAGCCGGAGCAGCCAGC
AACATCTACGACAATTTCGAGGTGCTGACCGGAGACCAGGTCACCGTTCGGTTCGTAATC
AACAATGCCACGACGGCGCTGGGACAGAATGTGTTCCTCACGGGCAATGTCAGCGAGCTG
GGCAACTGGGATCCGAACAACGCGATCGGCCCGATGTATAATCAGGTCGTCTACCAATAC
CCGACTTGGTATTATGATGTGAGCGTTCCGGCAGGCCAAACGATTGAATTTAAATTCCTG
AAAAAGCAAGGCTCCACCGTCACATGGGAAGGCGGCGCGAATCGCACCTTCACCACCCCA
ACCAGCGGCACGGCAACGGTGAATGTGAACTGGCAGCCTTAA

# Drug_Target_5_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_5_General_References:
2957361	Kimura K, Kataoka S, Ishii Y, Takano T, Yamane K: Nucleotide sequence of the beta-cyclodextrin glucanotransferase gene of alkalophilic Bacillus sp. strain 1011 and similarity of its amino acid sequence to those of alpha-amylases. J Bacteriol. 1987 Sep;169(9):4399-402.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2508

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
78341

# Drug_Target_5_Name:
Cyclomaltodextrin glucanotransferase

# Drug_Target_5_Number_of_Residues:
713

# Drug_Target_5_PDB_ID:
1UKQ

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF00686	CBM_20
PF01833	TIG
PF02806	Alpha-amylase_C

# Drug_Target_5_Protein_Sequence:
>Cyclomaltodextrin glucanotransferase precursor
MKRFMKLTAVWTLWLSLTLGLLSPVHAAPDTSVSNKQNFSTDVIYQIFTDRFSDGNPANN
PTGAAFDGSCTNLRLYCGGDWQGIINKINDGYLTGMGITAIWISQPVENIYSVINYSGVN
NTAYHGYWARDFKKTNPAYGTMQDFKNLIDTAHAHNIKVIIDFAPNHTSPASSDDPSFAE
NGRLYDNGNLLGGYTNDTQNLFHHYGGTDFSTIENGIYKNLYDLADLNHNNSSVDVYLKD
AIKMWLDLGVDGIRVDAVKHMPFGWQKSFMATINNYKPVFTFGEWFLGVNEISPEYHQFA
NESGMSLLDFRFAQKARQVFRDNTDNMYGLKAMLEGSEVDYAQVNDQVTFIDNHDMERFH
TSNGDRRKLEQALAFTLTSRGVPAIYYGSEQYMSGGNDPDNRARLPSFSTTTTAYQVIQK
LAPLRKSNPAIAYGSTHERWINNDVIIYERKFGNNVAVVAINRNMNTPASITGLVTSLRR
ASYNDVLGGILNGNTLTVGAGGAASNFTLAPGGTAVWQYTTDATTPIIGNVGPMMAKPGV
TITIDGRGFGSGKGTVYFGTTAVTGADIVAWEDTQIQVKIPAVPGGIYDIRVANAAGAAS
NIYDNFEVLTGDQVTVRFVINNATTALGQNVFLTGNVSELGNWDPNNAIGPMYNQVVYQY
PTWYYDVSVPAGQTIEFKFLKKQGSTVTWEGGANRTFTTPTSGTATVNVNWQP

# Drug_Target_5_Reaction:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_5_Signals:
1-27

# Drug_Target_5_Specific_Function:
Cyclizes part of a 1,4-alpha-D-glucan chain by formation of a 1,4-alpha-D-glucosidic bond

# Drug_Target_5_SwissProt_ID:
P05618

# Drug_Target_5_SwissProt_Name:
CDGT_BACS0

# Drug_Target_5_Synonyms:
CGTase
Cyclodextrin-glycosyltransferase
Cyclomaltodextrin glucanotransferase precursor
EC 2.4.1.19

# Drug_Target_5_Theoretical_pI:
5.76

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB03206
